Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Invested Capital (2020 - 2023)

Historic Return on Invested Capital for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to 0.19%.

  • ADC Therapeutics' Return on Invested Capital fell 1800.0% to 0.19% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.19%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.0% for FY2022, which is N/A changed from last year.
  • As of Q3 2023, ADC Therapeutics' Return on Invested Capital stood at 0.19%, which was down 1800.0% from 0.18% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Invested Capital ranged from a high of 0.0% in Q3 2022 and a low of 2157.54% during Q3 2021
  • For the 4-year period, ADC Therapeutics' Return on Invested Capital averaged around 316.87%, with its median value being 0.36% (2023).
  • Per our database at Business Quant, ADC Therapeutics' Return on Invested Capital tumbled by -21556600bps in 2021 and then surged by 21575400bps in 2022.
  • Quarter analysis of 4 years shows ADC Therapeutics' Return on Invested Capital stood at 1.89% in 2020, then skyrocketed by 62bps to 0.72% in 2021, then soared by 56bps to 0.32% in 2022, then surged by 41bps to 0.19% in 2023.
  • Its Return on Invested Capital stands at 0.19% for Q3 2023, versus 0.18% for Q2 2023 and 0.36% for Q1 2023.